308 related articles for article (PubMed ID: 31199439)
1. The process of prioritization of non-communicable diseases in the global health policy arena.
Heller O; Somerville C; Suggs LS; Lachat S; Piper J; Aya Pastrana N; Correia JC; Miranda JJ; Beran D
Health Policy Plan; 2019 Jun; 34(5):370-383. PubMed ID: 31199439
[TBL] [Abstract][Full Text] [Related]
2. Political priority and pathways to scale-up of childhood cancer care in five nations.
Denburg AE; Ramirez A; Pavuluri S; McCann E; Shah S; Alcasabas T; Antillon F; Arora R; Fuentes-Alabi S; Renner L; Lam C; Friedrich P; Maser B; Force L; Galindo CR; Atun R
PLoS One; 2019; 14(8):e0221292. PubMed ID: 31425526
[TBL] [Abstract][Full Text] [Related]
3. Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.
Bakhtiari A; Takian A; Majdzadeh R; Haghdoost AA
BMC Public Health; 2020 Mar; 20(1):333. PubMed ID: 32171267
[TBL] [Abstract][Full Text] [Related]
4. Non-communicable disease prevention policy process in five African countries.
Juma PA; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Mapa-Tassou C; Oluwasanu M; Oladepo O; Abiona O; Nkhata MJ; Wisdom JP; Mbanya JC
BMC Public Health; 2018 Aug; 18(Suppl 1):961. PubMed ID: 30168393
[TBL] [Abstract][Full Text] [Related]
5. Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases.
Suzuki M; Webb D; Small R
Int J Health Policy Manag; 2022 Jul; 11(7):1078-1089. PubMed ID: 33619925
[TBL] [Abstract][Full Text] [Related]
6. Challenges in policy reforms for non-communicable diseases: the case of diabetes in Kenya.
Shiroya V; Neuhann F; Müller O; Deckert A
Glob Health Action; 2019; 12(1):1611243. PubMed ID: 31117896
[No Abstract] [Full Text] [Related]
7. Establishing political priority for global mental health: a qualitative policy analysis.
Iemmi V
Health Policy Plan; 2022 Sep; 37(8):1012-1024. PubMed ID: 35763373
[TBL] [Abstract][Full Text] [Related]
8. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
[TBL] [Abstract][Full Text] [Related]
9. Responding to non-communicable diseases in Zambia: a policy analysis.
Mukanu MM; Zulu JM; Mweemba C; Mutale W
Health Res Policy Syst; 2017 Apr; 15(1):34. PubMed ID: 28438177
[TBL] [Abstract][Full Text] [Related]
10. A qualitative study of governance of evolving response to non-communicable diseases in low-and middle- income countries: current status, risks and options.
Rani M; Nusrat S; Hawken LH
BMC Public Health; 2012 Oct; 12():877. PubMed ID: 23067232
[TBL] [Abstract][Full Text] [Related]
11. Multi-sectoral action in non-communicable disease prevention policy development in five African countries.
Juma PA; Mapa-Tassou C; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Oluwasanu M; Mbanya JC; Nkhata MJ; Asiki G; Kyobutungi C
BMC Public Health; 2018 Aug; 18(Suppl 1):953. PubMed ID: 30168391
[TBL] [Abstract][Full Text] [Related]
12. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
Buse K; Tanaka S; Hawkes S
Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
[TBL] [Abstract][Full Text] [Related]
13. Strengthening implementation of diet-related non-communicable disease prevention strategies in Fiji: a qualitative policy landscape analysis.
Mounsey S; Waqa G; McKenzie B; Reeve E; Webster J; Bell C; Thow AM
Global Health; 2022 Sep; 18(1):79. PubMed ID: 36050736
[TBL] [Abstract][Full Text] [Related]
14. Legal priorities for prevention of non-communicable diseases: innovations from WHO's Eastern Mediterranean region.
Gostin LO; Abou-Taleb H; Roache SA; Alwan A
Public Health; 2017 Mar; 144():4-12. PubMed ID: 28274382
[TBL] [Abstract][Full Text] [Related]
15. The importance of prioritizing politics in Good Governance for Medicines Initiative in Zimbabwe: a qualitative policy analysis study.
Mhazo AT; Maponga CC
Health Policy Plan; 2022 May; 37(5):634-643. PubMed ID: 35106585
[TBL] [Abstract][Full Text] [Related]
16. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB
Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604
[TBL] [Abstract][Full Text] [Related]
17. The process of building the priority of neglected tropical diseases: A global policy analysis.
Aya Pastrana N; Beran D; Somerville C; Heller O; Correia JC; Suggs LS
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008498. PubMed ID: 32785262
[TBL] [Abstract][Full Text] [Related]
18. The International Society for Behavioral Medicine (ISBM) and the Society of Behavioral Medicine (SBM) advocate for the inclusion of behavioral scientists in the implementation of the Global Action Plan for the prevention of non-communicable diseases (NCDs) in low- and middle-income countries.
Odukoya O; Fox RS; Hayman LL; Penedo FJ
Transl Behav Med; 2021 Jun; 11(6):1286-1288. PubMed ID: 33410489
[TBL] [Abstract][Full Text] [Related]
19. Mitigating the Rising Burden of Non-Communicable Diseases through Locally Generated Evidence-Lessons from Tanzania.
Ndumwa HP; Amani DE; Ngowi JE; Njiro BJ; Munishi C; Mboya EA; Mloka D; Kikula AI; Balandya E; Ruggajo P; Kessy AT; Kitambala E; Kapologwe N; Kengia JT; Kiologwe J; Ubuguyu O; Salum B; Kamuhabwa A; Ramaiya K; Sunguya BF
Ann Glob Health; 2023; 89(1):77. PubMed ID: 38025921
[TBL] [Abstract][Full Text] [Related]
20. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.
NCD Countdown 2030 collaborators
Lancet; 2018 Sep; 392(10152):1072-1088. PubMed ID: 30264707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
